Beranda › HIV
Uji klinis HIV yang merekrut di AS
137 studi untuk HIV merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Washington, DC22 studi
- New York City, NY18 studi
- Miami, FL17 studi
- Houston, TX17 studi
- Baltimore, MD16 studi
- San Francisco, CA15 studi
- Atlanta, GA14 studi
- Chicago, IL14 studi
- Philadelphia, PA11 studi
- Boston, MA11 studi
- San Diego, CA10 studi
- Los Angeles, CA9 studi
- Seattle, WA8 studi
- Columbus, OH7 studi
- Birmingham, AL7 studi
- New Haven, CT7 studi
- Orlando, FL7 studi
- Dallas, TX7 studi
- Durham, NC6 studi
- West Palm Beach, FL6 studi
- Aurora, CO5 studi
- Newark, NJ5 studi
- Winston-Salem, NC5 studi
- Kansas City, MO5 studi
- Port Saint Lucie, FL5 studi
- Salt Lake City, UT5 studi
- New Orleans, LA5 studi
- The Bronx, NY5 studi
- Tampa, FL5 studi
- Greensboro, NC4 studi
- St. Louis, MO4 studi
- Cincinnati, OH4 studi
- Las Vegas, NV4 studi
- Nashville, TN4 studi
- Jacksonville, FL4 studi
- Burbank, CA4 studi
- Pittsburgh, PA3 studi
- Austin, TX3 studi
- Minneapolis, MN3 studi
- Miami Gardens, FL3 studi
Berdasarkan negara bagian
- Alabama9 studi
- California33 studi
- Colorado7 studi
- Connecticut8 studi
- Distrik Columbia9 studi
- Florida26 studi
- Georgia14 studi
- Illinois14 studi
- Kentucky3 studi
- Louisiana6 studi
- Maryland29 studi
- Massachusetts12 studi
- Michigan4 studi
- Minnesota3 studi
- Missouri8 studi
- Nevada4 studi
- New Jersey6 studi
- New York22 studi
- North Carolina13 studi
- Ohio10 studi
- Pennsylvania11 studi
- Tennessee7 studi
- Texas23 studi
- Utah5 studi
- Virginia4 studi
- Washington8 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07473778Quitting Matters Human Immunodeficiency Virus Hybrid Trial
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06883097A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07650916Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00006518Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants
Menerima pesertaStudi observasional
Usia 18 hingga 120 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00039689Viral Load in Blood and Lymph Tissues in People Living With HIV
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT00001316Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT03300830HIV and Alcohol Research Center Focused on Polypharmacy (HARP) Pilot 2 (2nd HARP Pilot Intervention)
Menerima pesertaFase 1
Usia 50 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06513819Leukapheresis to Obtain Plasma or Lymphocytes for Studies of HIV-infected Patients, Including Long-term Non-progressors
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT00029445El Camino HIV Prevention and Care Study
Menerima peserta
Usia 18 ke atas · Pria · Diperbarui 22 Sep 2026 · NCT07834853Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05419024Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 12 hingga 120 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT05470491ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT06274632A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities
Menerima pesertaSukarelawan sehat diterima
Usia 15 hingga 26 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06428643The TAIL-PrEP Study
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT06868641A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Menerima pesertaFase 2/3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07266831Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
Menerima pesertaFase 1Sukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06665646Couples Motivational Interviewing to Reduce Drug Use and HIV Risk in Vulnerable Male Couples
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 55 · Pria · Diperbarui 17 Sep 2026 · NCT06307977Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
Menerima pesertaFase 1
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT04902443A Remotely Delivered Tai Chi/Qigong Intervention for Older People Living With HIV
Menerima peserta
Usia 50 hingga 75 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06586619Observational Pharmaco-Epidemiology Research & Analysis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT03813862PRIDE III Prison Interventions and HIV Prevention Collaboration
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT06962033Development and Evaluation of a Virtual Reality Tool for At-Risk Trauma-Exposed Young People
Menerima pesertaSukarelawan sehat diterima
Usia 15 hingga 30 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT05816083Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Menerima pesertaFase 1/2
48 Hours · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT02140255SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT00187512Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.